These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 22305264
1. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands]. Hernández-Cairo A, Perera-Pintado A, Prats-Capote A, Batista-Cuellar JF, Casacó-Santana C. Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264 [Abstract] [Full Text] [Related]
3. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V. Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877 [Abstract] [Full Text] [Related]
9. 99m Tc-(EDDA/tricine)-HYNIC-GnRH analogue as a potential imaging probe for diagnosis of prostate cancer. Masteri Farahani A, Maleki F, Sadeghzadeh N, Abediankenari S, Abedi SM, Erfani M. Chem Biol Drug Des; 2020 Aug 19; 96(2):850-860. PubMed ID: 32279449 [Abstract] [Full Text] [Related]
10. Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging. Aranda-Lara L, Ferro-Flores G, Ramírez Fde M, Ocampo-García B, Santos-Cuevas C, Díaz-Nieto L, Isaac-Olivé K. Nucl Med Commun; 2016 Apr 19; 37(4):377-86. PubMed ID: 26657220 [Abstract] [Full Text] [Related]
11. An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor. Khodadust F, Ahmadpour S, Aligholikhamseh N, Abedi SM, Hosseinimehr SJ. Eur J Med Chem; 2018 Jan 20; 144():767-773. PubMed ID: 29291444 [Abstract] [Full Text] [Related]
12. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer. Shi J, Jia B, Liu Z, Yang Z, Yu Z, Chen K, Chen X, Liu S, Wang F. Bioconjug Chem; 2008 Jun 20; 19(6):1170-8. PubMed ID: 18491928 [Abstract] [Full Text] [Related]
15. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R. Nucl Med Biol; 2006 Nov 20; 33(8):945-52. PubMed ID: 17127166 [Abstract] [Full Text] [Related]
16. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours. Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT. Nucl Med Commun; 2006 Apr 20; 27(4):371-6. PubMed ID: 16531924 [Abstract] [Full Text] [Related]
17. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model. Ananias HJ, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH. Mol Pharm; 2011 Aug 01; 8(4):1165-73. PubMed ID: 21699202 [Abstract] [Full Text] [Related]
18. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging. Garcia MF, Zhang X, Gallazzi F, Fernandez M, Moreno M, Gambini JP, Porcal W, Cabral P, Quinn TP. Anticancer Agents Med Chem; 2015 Aug 01; 15(1):122-30. PubMed ID: 25175799 [Abstract] [Full Text] [Related]